ATE309541T1 - Inter-alpha-trypsin als marker für sepsis - Google Patents

Inter-alpha-trypsin als marker für sepsis

Info

Publication number
ATE309541T1
ATE309541T1 AT01934830T AT01934830T ATE309541T1 AT E309541 T1 ATE309541 T1 AT E309541T1 AT 01934830 T AT01934830 T AT 01934830T AT 01934830 T AT01934830 T AT 01934830T AT E309541 T1 ATE309541 T1 AT E309541T1
Authority
AT
Austria
Prior art keywords
inter
sepsis
alpha
trypsin
marker
Prior art date
Application number
AT01934830T
Other languages
English (en)
Inventor
Yow-Pin Lim
Douglas C Hixson
Original Assignee
Rhode Island Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhode Island Hospital filed Critical Rhode Island Hospital
Application granted granted Critical
Publication of ATE309541T1 publication Critical patent/ATE309541T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01934830T 2000-02-28 2001-02-06 Inter-alpha-trypsin als marker für sepsis ATE309541T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/514,450 US6660482B1 (en) 2000-02-28 2000-02-28 Inter-alpha-trypsin inhibitor as a marker for sepsis
PCT/US2001/003827 WO2001063280A2 (en) 2000-02-28 2001-02-06 Inter-alpha-trypsin as a marker for sepsis

Publications (1)

Publication Number Publication Date
ATE309541T1 true ATE309541T1 (de) 2005-11-15

Family

ID=24047191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01934830T ATE309541T1 (de) 2000-02-28 2001-02-06 Inter-alpha-trypsin als marker für sepsis

Country Status (8)

Country Link
US (1) US6660482B1 (de)
EP (1) EP1295127B1 (de)
JP (1) JP4903965B2 (de)
AT (1) ATE309541T1 (de)
AU (2) AU6097901A (de)
CA (1) CA2401647A1 (de)
DE (1) DE60114823T2 (de)
WO (1) WO2001063280A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7015004B2 (en) * 2001-11-23 2006-03-21 Syn X Pharma, Inc. Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
US7132244B2 (en) * 2001-11-21 2006-11-07 Syn X Pharma, Inc. Betaine/GABA transport protein biopolymer marker indicative of insulin resistance
MXPA05005031A (es) 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
MXPA05005073A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
CA2505843A1 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
CA2544816A1 (en) * 2003-11-08 2005-05-26 Prothera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
CA2605143A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
US8221995B2 (en) 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
BRPI0913949A2 (pt) 2008-05-28 2015-10-20 Pro Thera Biolog Llc preparação e composição de proteínas inibidoras inter-alfa a partir de sangue
AU2009325088B2 (en) * 2008-12-10 2014-06-19 Duke University Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease
WO2014039987A2 (en) * 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
WO2018200722A1 (en) * 2017-04-25 2018-11-01 Prothera Biologics, Inc. Methods for quantifying inter-alpha inhibitor proteins
US20230055086A1 (en) * 2021-08-19 2023-02-23 Prothera Biologics, Inc. Inter-alpha inhibitor proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0401508T3 (da) * 1989-05-13 1995-05-15 Bayer Ag Proteaseinhibitorer, fremgangsmåde til deres fremstilling samt lægemidler med indhold deraf
US5166133A (en) 1991-04-17 1992-11-24 Cetus Corporation Method for inhibing adhesion of white blood cells to endothelial cells
FR2711371B1 (fr) 1993-10-18 1995-12-29 Aetsrn Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.
US5804370A (en) * 1994-06-08 1998-09-08 Critichem Medical Products Limited Early diagnosis of sepsis utilizing antigen-antibody interactions amplified by whole blood chemiluminescence
JP3327758B2 (ja) * 1995-12-11 2002-09-24 株式会社いかがく 肝線維化のスクリーニング方法及び診断用キット

Also Published As

Publication number Publication date
EP1295127A2 (de) 2003-03-26
DE60114823D1 (en) 2005-12-15
JP2004500568A (ja) 2004-01-08
WO2001063280A3 (en) 2003-01-23
AU6097901A (en) 2001-09-03
EP1295127B1 (de) 2005-11-09
CA2401647A1 (en) 2001-08-30
US6660482B1 (en) 2003-12-09
JP4903965B2 (ja) 2012-03-28
DE60114823T2 (de) 2006-08-03
AU2001260979B2 (en) 2006-09-28
WO2001063280A2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
ATE309541T1 (de) Inter-alpha-trypsin als marker für sepsis
IL252832B (en) Use of biomarkers to detect ovarian cancer
DE50304023D1 (de) Diagnose von Myokardinfarkt und akutem Koronarsyndrom durch Kombination von Markern
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2004099432A3 (en) Identification of biomarkers for detecting pancreatic cancer
DE60117592T8 (de) Diagnose von pre-eclampsia
DK1095278T3 (da) Differentialdiagnose af neurodegeneration
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
DE69223355D1 (de) Verfahren und Zusammensetzungen zum Nachweis von Serumproteasen, insbesondere für aktiviertes Protein C
DE60129314D1 (de) Diagnose von leberfibrose mit hilfe von serummarkeralgorithmen
WO2005012329A3 (en) Kinase and phosphatase assays
ATE184108T1 (de) Mca prüfung/kit zum nachweis von metallkationen
GB0420774D0 (en) Wound treatment system
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE60229043D1 (de) Rearrangierte plattenepithelkarzinomantigen-gene ii
ATE377192T1 (de) Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls
WO2001053835A3 (en) Methods for detecting cancer of the central nervous system
DE59709109D1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
WO2006013474A3 (en) PPGALNAC-t6 MRNA or peptide as a new marker for detection cancer cells
SE0100595D0 (sv) Immunological detection of prostate diseases and prostatic-related diseases
WO2004030521A3 (en) Use of biomarkers for detecting acute renal transplant rejection
ATE229183T1 (de) Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d- spiegels in körperflüssigkeiten
Takeda et al. Enzyme-linked immunosorbent assay for the detection of cathepsin-kininogen complexes in human plasma
ATE405646T1 (de) Ein verfahren zum auffinden vom prostatakrebs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1295127

Country of ref document: EP